1. Clinical utility of EBUS‐TBNA of hilar, interlobar, and lobar lymph nodes in patients with primary lung cancer
- Author
-
Seungbum Wi, Bo‐Guen Kim, Sun Hye Shin, Byung Woo Jhun, Hongseok Yoo, Byeong‐Ho Jeong, Kyungjong Lee, Hojoong Kim, O Jung Kwon, Joungho Han, Jhingook Kim, and Sang‐Won Um
- Subjects
endobronchial ultrasound‐guided transbronchial needle aspiration ,hilar lymph nodes ,lung cancer ,mediastinum ,staging ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) is used to evaluate hilar/interlobar/lobar lymph nodes. This study aimed to assess the clinical utility of EBUS‐TBNA for station 10/11/12 lymph nodes (LNs) in patients with primary lung cancer. Methods This was a retrospective analysis of a prospectively collected database of patients with primary lung cancer who underwent EBUS‐TBNA for station 10/11/12 LNs from January 2015 to December 2019. Patients with benign results from EBUS‐TBNA who did not undergo surgical sampling/clinical follow‐up or who received radiotherapy/chemotherapy were excluded. Results The analyses were conducted on 889 LNs from 797 patients. The overall diagnostic sensitivity, specificity, accuracy, negative predictive value (NPV), and positive predictive value of EBUS‐TBNA were 95.7, 100, 97.3, 93.2, and 100%, respectively. Diagnostic sensitivity was significantly lower for LNs
- Published
- 2022
- Full Text
- View/download PDF